Camptothecins and Topoisomerase I; A Foot in the Door. Targeting the Genome Beyond Topoisomerase I with Camptothecins and Novel Anticancer Drugs; Importance of DNA Replication, Repair and Cell Cycle Checkpoints
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
429-434
Author(s):
Yves Pommier
Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
445-447
Author(s):
Edward A. Sausville
Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
449-455
Author(s):
Tomi K. Sawyer
Resistance in Cancer: A Target for Drug Discovery
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
457-460
Author(s):
Mark Searcey and Laurence H. Patterson
p53: Fighting Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
385-402
Author(s):
Galina Selivanova
Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
403-424
Author(s):
M. C. Liu, J. L. Marshall and R. G. Pestell
Harnessing Changes in Cellular Glycosylation in New Cancer Treatment Strategies
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
425-442
Author(s):
M. V. Dwek and S. A. Brooks
Carcinoembryonic Antigen as a Target to Induce Anti-Tumor Immune Responses
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
443-454
Author(s):
P. Sarobe, E. Huarte, J. J. Lasarte and F. Borras-Cuesta
Antiandrogens in Prostate Cancer Endocrine Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
455-461
Author(s):
Z. Culig, G. Bartsch and A. Bartsch
DNAzymes: From Creation In Vitro to Application In Vivo
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
321-336
Author(s):
J. C. Achenbach, W. Chiuman, R. P.G. Cruz and Y. Li